Hamilton House, 844 Quail Point Cove, Virginia Beach, VA 23454, USA.
Arch Immunol Ther Exp (Warsz). 2010 Aug;58(4):255-61. doi: 10.1007/s00005-010-0080-3. Epub 2010 May 28.
Substantial confusion exists about the role of medical writers and editors (hereafter, medical communicators) in medical publication. Much of the confusion is due to the failure to recognize the difference between terms. Ghostwriting is unethical, whereas professional medical communication refers to legitimate writing and editing services provided by individuals who comply with ethical guidelines. The purpose of this article is to shed light on this subject by reviewing relevant guidelines and by providing practical tips for authors interested in collaborating with medical communicators. Specifically, this article addresses a series of questions, such as what to expect from medical communicators, how to evaluate them, and how to collaborate ethically and efficiently with them. To ensure that the process is ethical, authors should begin collaborating with the medical communicator early in the process, continue doing so throughout manuscript development, and control manuscript content. In addition, authors should disclose substantial contributions and funding sources of the medical communicator and all other individuals not meeting authorship criteria. To ensure that the process is efficient, authors should delegate time-consuming technical writing and editing tasks to the medical communicator.
医学作家和编辑（以下简称医学传播者）在医学出版中的作用存在很大的混淆。造成这种混淆的很大一部分原因是未能认识到术语之间的区别。代写是不道德的，而专业的医学传播则是指符合道德准则的个人提供的合法写作和编辑服务。本文旨在通过审查相关指南，并为有兴趣与医学传播者合作的作者提供实用提示，来阐明这一主题。具体来说，本文解决了一系列问题，例如作者可以从医学传播者那里期待什么，如何评估他们，以及如何与他们进行合乎道德且高效的合作。为了确保过程合乎道德，作者应在早期就开始与医学传播者合作，在整个手稿开发过程中继续合作，并控制手稿内容。此外，作者应披露医学传播者和所有不符合作者标准的其他个人的实质性贡献和资金来源。为了确保过程高效，作者应将耗时的技术写作和编辑任务委托给医学传播者。
